Device
AutoloGel
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Completion Rate
0%(0/4)
Active Trials
0(0%)
Terminated
4(80%)
Phase Distribution
Ph not_applicable
4
80%
Ph phase_4
1
20%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
4(80.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 5 finished
Non-Completion Rate
100.0%
5 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Terminated(5)
Detailed Status
Terminated4
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
0.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (20.0%)
N/A4 (80.0%)
Trials by Status
withdrawn120%
terminated480%
Recent Activity
0 active trials
Showing 5 of 5
terminatednot_applicable
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
NCT01816633
withdrawnphase_4
A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers
NCT02248077
terminatednot_applicable
AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers
NCT01819142
terminatednot_applicable
Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.
NCT01816672
terminatednot_applicable
A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers
NCT01817543
Clinical Trials (5)
Showing 5 of 5 trials
NCT01816633Not Applicable
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
NCT02248077Phase 4
A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers
NCT01819142Not Applicable
AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers
NCT01816672Not Applicable
Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.
NCT01817543Not Applicable
A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5